At a time when drugs can take a decade from discovery to market, and as Big Pharma develops fewer drugs, a growing number of researchers are betting on old drugs.
Miami-Dade County became the latest in a slew of counties and cities seeking litigation against the pharmaceutical industry for its alleged role in the opioid crisis.
Investigators are closing in on Big Pharma, claiming that shady tactics fueled the opioid crisis.
Psychiatric medications are being overprescribed, but in some cases, these drugs save lives. We need a more nuanced approach to treatment.
Democracy Forward is suing for details about a former pharmaceutical lobbyist's role in drug regulation.
The use of nitroprusside and isoproterenol dropped by 53 percent and 35 percent over three years, as their prices skyrocketed by factors of ten.
The Republican senators working on the Obamacare repeal-and-replace bill have received hundreds of thousands in campaign contributions from the two big lobbies.
The state believes drug companies misled consumers about the risks and benefits of their painkillers.
Pharmacy benefit managers arose to fulfill a need created by the Medicare Modernization Act. But now these companies are contributing to escalating drug prices, the very opposite of their original purpose.
Without laws to enforce them, the president's ideas to control drug prices will do just the opposite.
A fractured regulatory system hampered by Big Pharma's meddling has led to a growing global falsification market.